Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 37:2086-2092
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsutamoto, T.
Right arrow Articles by Kinoshita, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsutamoto, T.
Right arrow Articles by Kinoshita, M.

Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy

Takayoshi Tsutamoto, MDa, Atsuyuki Wada, MDa, Tetsuya Matsumoto, MDa, Keiko Maeda, MDa, Naoko Mabuchi, MDa, Masaru Hayashi, MDa, Takashi Tsutsui, MDa, Masato Ohnishi, MDa, Masahide Sawaki, MDa, Masanori Fujii, MDa, Takehiro Matsumoto, MDa, Takashi Yamamoto, MDa, Hajime Horie, MDa, Yoshihisa Sugimoto, MDa and Masahiko Kinoshita, MDa

a First Department of Internal Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu, Japan



View larger version (17K):

[in a new window]
 
Figure 1 Plasma oxidized low density lipoprotein (oxLDL) concentrations in the aortic root (AO), coronary sinus (CS) and femoral vein (FV) in 8 control subjects and in 22 patients with dilated cardiomyopathy. Open columns represent control subjects; closed columns represent patients with dilated cardiomyopathy. *p < 0.05; **p < 0.01 between the value of normal subjects and patients with dilated cardiomyopathy; #p < 0.01 vs. the value of AO by analysis of variance with the Scheffé F test.

 


View larger version (21K):

[in a new window]
 
Figure 2 Correlation between the transcardiac gradient of plasma oxidized low density lipoprotein (oxLDL) and left ventricular ejection fraction (LVEF). AO = aortic root; CS = coronary sinus; open triangles represent control subjects; open circles represent patients with dilated cardiomyopathy.

 


View larger version (22K):

[in a new window]
 
Figure 3 Correlation between the transcardiac gradient of plasma oxidized low density lipoprotein (oxLDL) and left ventricular end-diastolic volume index (LVEDVI). AO = aortic root; CS = coronary sinus; open triangles represent control subjects; open circles represent patients with dilated cardiomyopathy.

 


View larger version (18K):

[in a new window]
 
Figure 4 Comparison of the transcardiac gradient of oxidized low density lipoprotein (oxLDL) between 6 patients who received carvedilol and 16 patients who did not receive carvedilol. AO = aortic root; CS = coronary sinus. *p < 0.05 vs. carvedilol (–).

 


View larger version (22K):

[in a new window]
 
Figure 5 Correlation between the transcardiac gradient of plasma tumor necrosis factor-alpha (TNF-alpha) and the transcardiac gradient of plasma oxidized low density lipoprotein (oxLDL) in patients with dilated cardiomyopathy. AO = aortic root; CS = coronary sinus.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement